![](/img/cover-not-exists.png)
Phase I study of cisplatin, irinotecan, and epirubicin administered every 3 weeks in patients with advanced solid tumours
Chen, X, Oza, A M, Kusenda, Z, Yi, Q-L, Kochman, D, Moore, M J, Davis, A J, Siu, L LVolume:
89
Year:
2003
Language:
english
Pages:
8
DOI:
10.1038/sj.bjc.6601147
File:
PDF, 127 KB
english, 2003